Filing Details EASTERN BANK, a registered investment adviser, increased its position in Johnson & Johnson (NYSE:JNJ) by 217.8% during Q2 2026, according to its most recent 13F…
EASTERN BANK, a registered investment adviser, increased its position in Johnson & Johnson (NYSE:JNJ) by 217.8% during Q2 2026, according to its most recent 13F filing with the Securities and Exchange Commission.
The firm purchased an additional 78,198 shares of the Healthcare company, bringing its total holdings to 114,094 shares valued at approximately $29.0M as of the filing date.
Johnson & Johnson's stock currently trades at $257.35 with a market capitalization of $505.8B.
An increase in an existing position suggests EASTERN BANK has growing conviction in Johnson & Johnson's trajectory. Institutional investors typically add to positions when they believe the stock still has upside relative to their price target, or when the company's fundamentals have improved since their initial purchase.
Healthcare stocks have attracted institutional attention as an aging population drives long-term demand. Johnson & Johnson operates in a sector where regulatory developments and pipeline progress can significantly impact institutional positioning.
Investors should note that 13F filings reflect holdings as of the end of the reporting quarter and are filed up to 45 days later. The position may have changed since the filing date. 13F data is most useful when analyzed alongside other signals such as insider transactions, analyst ratings, and fundamental trends.
Related Tools: Insider Trades Tracker | View JNJ Stock Page
A 13F filing is a quarterly SEC report required for institutional managers with over $100 million in assets. It discloses equity holdings, providing transparency into how firms like EASTERN BANK position their portfolios.
View all institutional holders on our JNJ institutional ownership page.
Current market data
NYSE · JNJ
$267.20
Up: +$0.88 · +0.33%
Live quote updated
Keep reading
